Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Innovative Medical
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
· Male or female \> 18 years of age
* Documented low-responder to latanoprost therapy as delineated in the outline above.
* Diagnosis of open-angle glaucoma or ocular hypertension
* Ability to provide informed consent and likely to complete all study visits
You may not be if
· Known contraindication to bimatoprost or any component of any study medication
* Uncontrolled systemic disease
* Active ocular disease other than glaucoma or ocular hypertension
* Required use of ocular medications other than the study medications during the study (intermittent use of artificial tear solutions will be permitted)
* History of intraocular surgery within the last 3 months
Clareo Health | Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost
